Clinical trial

Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population

NCT02316522

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-10-23

PhaseN/A

Study timeline

Study start (actual)2014-10-23Date precision: day

Registry last updated2022-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

Sponsors & collaborators

Weill Medical College of Cornell Universitylead sponsor

Hamad Medical Corporationcollaborator

Weill Cornell Medical College in Qatarcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02316522 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.